A NOVEL-APPROACH TO ASSESS CHANGES IN ENDOCRINE SECRETION - ANALYSIS OF GNRH ANTAGONIST (NAL-GLU) SUPPRESSION OF GONADOTROPIN-RELEASE IN OVARIECTOMIZED EWES
Dp. Normolle et al., A NOVEL-APPROACH TO ASSESS CHANGES IN ENDOCRINE SECRETION - ANALYSIS OF GNRH ANTAGONIST (NAL-GLU) SUPPRESSION OF GONADOTROPIN-RELEASE IN OVARIECTOMIZED EWES, European journal of endocrinology, 136(5), 1997, pp. 519-530
Circulating hormone levels reflect the outcome of multiple feedback sy
stems, A method to accurately assess the dynamics of hormonal changes
in samples collected at infrequent intervals and compare these dynamic
processes among treatment groups is presented. In this approach, a sm
ooth curve is fitted to each time series of concentrations produced in
an experiment, the curves are summarized by numerical measurements, a
nd the measurements are subjected to statistical analysis. The method
is demonstrated on data from an experiment that explores the different
ial effects of a competitive GnRH receptor antagonist (Nal-Glu) on cir
culating levels of LH and FSH. In this experiment, six adult ovariecto
mized Suffolk ewes were treated with one of three doses of Nal-Glu usi
ng a crossover design, LH and FSH concentrations were determined in ho
urly samples of jugular blood for 24 h after treatment. Applying the a
nalytical approach, we observed differential effects of increasing con
centrations of Nal-Glu on circulating LH and FSH concentrations, The m
agnitude of LH suppression was similar from dose to dose, while the du
ration of LH suppression was dose-dependent, In contrast, all doses of
Nal-Glu elicited similar effects on the amplitude, duration and time
to recovery of FSH suppression, Studies conducted in vitro utilizing d
ispersed ovine pituitary cells in culture demonstrated that the differ
ential effects of Nal-Glu on FSH and LH secretion were not the outcome
of differential sensitivity of FSH and LH to GnRH. The differential e
ffects of Nal-Glu on circulating LH and FSH concentrations may be due
to a number of factors, including other releasing or release-inhibitin
g hormones, paracrine modulators involved in selective regulation of F
SH, and/or differences in clearances.